Backtested Scanners
Revenue Inflection
6 Hits · last calculated August 8, 2026 Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Market filter active: the list shows 0 hits from Germany
Methodology & criteria
The fresh kink in the revenue curve: the most recent two or more quarters each grow 30–70 % against their year-ago quarter, while the four quarters before that each grew by less than 15 %. A band instead of a floor — a company growing at triple digits is no longer at the start. Only from $100 million of revenue upwards (sum of the last four quarters): in the 2013–2026 backtest the signal only carried on that revenue base — across all purchases 21.7 % per year against 5.8 % between $10 million and $100 million and 3.2 % below — smaller stocks are missing from the list by design. The fresh inflections (organic, held twelve months) ran ahead of the already-established growers; on the conservative count 16.6 % versus 9.9 % per year. Only the early phase is listed, therefore: at most two accelerating quarters. From the third onwards the entry point the backtest measured has passed — buying then returned 0.7 % per year, and the company drops off the list. Source: fundamental data.
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) and names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
🔔 Watch scanner
Hit List
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Revenue Base ($M) | Accelerating Quarters | Earnings | Avg/Y 3Y | Stress RS | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Growth Score | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No stocks currently pass this scanner. | |||||||||||||||||||||||||||||||||||||||||||||||
Frequently Asked Questions
The fresh kink in the revenue curve: the most recent two or more quarters each grow 30–70 % against their year-ago quarter, while the four quarters before that each grew by less than 15 %. A band instead of a floor — a company growing at triple digits is no longer at the start.
All scanners are recalculated daily across the entire stock universe — most recently on 8. August 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 6 stocks pass this scanner's criteria (as of 8. August 2026).
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) and names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
The scanner looks for the start of a growth story, not its middle. Two conditions have to come together: the most recent two or more consecutive quarters each grow 30% to 70% against their year-ago quarter, and the four quarters immediately before that each grew by less than 15%. The 70% ceiling is deliberate — a company growing at triple digits is no longer at the start, it is in the middle of a story the market has long since priced in. The four quiet quarters have to be on the record: if the history is missing because the company only recently listed, that counts as "not on record", not as "quiet". On top of that comes a hurdle that does not come from the rule but from measuring it: at least $100 million of revenue over the last four quarters. Split by revenue base, the signal only carried there: across all purchases 21.7% per year against 5.8% between $10 million and $100 million and 3.2% below, and for the fresh inflections alone 21.9% against 7.8% and 4.5% — a jump from $117,000 to $155,000 is statistically hard to tell apart from noise. Smaller stocks are therefore missing by design. We backtested the rule from 2013 to 2026 on a database that includes delisted stocks and keeps them in the portfolio. On a twelve-month holding period and restricted to organically grown companies: 26.3% per year for the fresh inflections versus 19.4% for companies that were already growing, 15.0% for the S&P 500 including dividends and 4.8% for the equal-weighted universe. Removing 16 of 2,684 positions whose monthly jump above 200% points to reverse splits that were never carried into the adjusted price leaves 16.6% versus 9.9% — the ranking holds, the level halves. And a second limit, for the same reason: only the early phase is listed, at most two accelerating quarters. Buying only from the third onwards returned 0.7% per year — from there a company drops back off the list. The main arm held a median of just 15 stocks per month — a narrow base. Every figure and caveat is in the study. A hit is a find, not a buy signal. Source: fundamental data and SEC filings (annual reports 10-K and quarterly reports 10-Q).
Related scanners
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.